Literature DB >> 25428341

Effectiveness of Bushen Huoxue Granule (补肾活血颗粒) on 5-serotonin and norepinephrine in the brain of Parkinson's disease patients with depressive state.

Hai-Ming Wang1, Ming-Hui Yang, Yi Liu, Shao-Dan Li, Min Li.   

Abstract

OBJECTIVE: To observe the clinical curative effect of Chinese medicine Bushen Huoxue Granule(补肾活血颗粒, BHG) on Parkinson's disease (PD) patients with depressive state.
METHODS: Sixty-two PD patients with depressive state were randomly assigned to two groups by using a random number table, 31 in each group. Madopar was given to all as the conventional treatment. The fluoxetine hydrochloride dispersible tablet was given to the patients in the control group and BHG was given to those in the treatment group. The therapeutic course for all was 12 weeks. Before and after treatment, Hamilton depression rating scale (HAMD) was applied to judge the curative effect, and the changes of cerebral neurotransmitters levels in the brain of patients were detected by encephalofluctuograph technique.
RESULTS: The scores of HAMD in the two groups were decreased markedly after 12-week treatment. It was lower in the treatment group than that in the control group with significant difference (P<0.01). The contents of norepinephrine (NE) and 5-serotonin (5-HT) in the PD patients were obviously lower than normal value. There was no significant difference between the two groups before treatment (P>0.05). The contents of NE and 5-HT were all increased in the two groups after treatment (P<0.05), with significant differences between the two groups (P<0.01).
CONCLUSION: BHG could increase the contents of NE and 5-HT in PD patients' brain to improve the depressive state of PD patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25428341     DOI: 10.1007/s11655-014-2029-6

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  10 in total

1.  Subthreshold depression in Parkinson's disease.

Authors:  Daniel A Nation; Heather L Katzen; Spyridon Papapetropoulos; Blake K Scanlon; Bonnie E Levin
Journal:  Int J Geriatr Psychiatry       Date:  2009-09       Impact factor: 3.485

2.  The correlation of depression with functional activity in Parkinson's disease.

Authors:  C Y Liu; S J Wang; J L Fuh; C H Lin; Y Y Yang; H C Liu
Journal:  J Neurol       Date:  1997-08       Impact factor: 4.849

3.  [Effects of Bushen Huoxue Granule on motor function in patients with Parkinson's disease: a multicenter, randomized, double-blind and placebo-controlled trial].

Authors:  Ming-hui Yang; Min Li; Yong-qi Dou; Yi Liu; Xiao-dong Luo; Jian-zong Chen; Heng-jun Shi
Journal:  Zhong Xi Yi Jie He Xue Bao       Date:  2010-03

4.  Effect of Bushen Huoxue Decoction on the orphan receptor and tyrosine hydroxylase in the brain of rats with Parkinson's disease.

Authors:  Ming-Hui Yang; Hai-Ming Wang; Yi Liu
Journal:  Chin J Integr Med       Date:  2011-01-22       Impact factor: 1.978

Review 5.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

Review 6.  Imaging in Parkinson's disease: the role of monoamines in behavior.

Authors:  David J Brooks; Paola Piccini
Journal:  Biol Psychiatry       Date:  2006-04-11       Impact factor: 13.382

7.  HMPAO SPECT in Parkinson's disease (PD) with major depression (MD) before and after antidepressant treatment.

Authors:  Sven E Pålhagen; Stefan Ekberg; Jan Wålinder; Ann-Kathrine Granérus; Göran Granerus
Journal:  J Neurol       Date:  2009-05-10       Impact factor: 4.849

8.  Social support plays a role in depression in Parkinson's disease: a cross-section study in a Chinese cohort.

Authors:  Yanbo Cheng; Chunfeng Liu; Chengjie Mao; Jinjun Qian; Kangyong Liu; Guoxiu Ke
Journal:  Parkinsonism Relat Disord       Date:  2007-07-09       Impact factor: 4.891

9.  Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system.

Authors:  Philippe Remy; Miroslava Doder; Andrew Lees; Nora Turjanski; David Brooks
Journal:  Brain       Date:  2005-02-16       Impact factor: 13.501

Review 10.  Impact of the novel antidepressant agomelatine on disturbed sleep-wake cycles in depressed patients.

Authors:  Maria-Antonia Quera-Salva; Patrick Lemoine; Christian Guilleminault
Journal:  Hum Psychopharmacol       Date:  2010-04       Impact factor: 1.672

  10 in total
  1 in total

Review 1.  Therapies for Parkinson's diseases: alternatives to current pharmacological interventions.

Authors:  Song Li; Jie Dong; Cheng Cheng; Weidong Le
Journal:  J Neural Transm (Vienna)       Date:  2016-08-11       Impact factor: 3.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.